Risks and Benefits of Erythropoiesis-Stimulating Agents in Cancer Management
To access this article, please choose from the options below
PII: S0037-1963(07)00067-4
doi:10.1053/j.seminhematol.2007.04.004
© 2007 Elsevier Inc. All rights reserved.
PII: S0037-1963(07)00067-4
doi:10.1053/j.seminhematol.2007.04.004
© 2007 Elsevier Inc. All rights reserved.